Supernus Pharmaceutucals asks FDA to approve new ADHD drug

A Rockville drug company working on treatments for central nervous system diseases has asked the Food and Drug Administration to approve the sale and marketing of a new drug to treat attention deficit hyperactivity disorder.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.